glp-1 and thyroid cancer Implications of Receptor Agonist on Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality TSH Levels GLP-1 and Family History of

Pendulum GLP-1 Probiotic is formulated by a team of PhD scientists from Johns Hopkins, Harvard, Berkeley and Stanford backed by Mayo Clinic, Sequoia Capital and over $111 million in research investment combining Akkermansia muciniphila with complementary probiotic strains specifically selected to support gut barrier integrity, microbiome diversity and the gut signalling environment associated with appetite and craving management

The second developed approach, body roundness index (BRI), associates a persons shape phenotype with high-risk adiposity components and multiple health outcomes

Support your healthy lifestyle with our innovative botanical patches, designed to complement your weight management

Trail registration Study registered in clinicaltrials.org with the identifier NCT05535322.

Unrealised Expectations Despite progress, several anticipated 2025 milestones did not come to fruition: Regulatory progress stalled: FDAs obesity drug guidance, published in draft form in January 2025, remains unfinalised, whilst EMA has yet to update its 2016 guideline